Carafate Suspension (Sucralfate) - Summary

SUMMARY

CARAFATE Suspension contains sucralfate and sucralfate is an α-D-glucopyranoside, β-D-fructofuranosyl-, octakis-(hydrogen sulfate), aluminum complex.

CARAFATE (sucralfate) Suspension is indicated in the short-term (up to 8 weeks) treatment of active duodenal ulcer.

NEWS HIGHLIGHTS RELATED TO CARAFATE SUSPENSION

Published Studies Related to Carafate Suspension (Sucralfate)

Anti-inflammatory Effects of Rebamipide According to Helicobacter pylori Status in Patients with Chronic Erosive Gastritis: A Randomized Sucralfate-Controlled Multicenter Trial in China-STARS Study. [2008.02.21]

A randomized placebo controlled trial of ranitidine versus sucralfate in patients with spontaneous intracerebral hemorrhage for prevention of gastric hemorrhage. [2005.12.15]

Sucralfate does not ameliorate acute radiation proctitis: randomised study and meta-analysis. [2005.09]

Effect of oral sucralfate on late rectal injury associated with radiotherapy for prostate cancer: A double-blind, randomized trial. [2004.11.15]

Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial. [2004.11]

more>>

Clinical Trials Related to Carafate Suspension (Sucralfate)

A Clinico-Bacteriological Study and Effect of Stress Ulcer Prophylaxis on Occurrence of Ventilator Associated Pneumonia [Completed]

Comparison of Esomeprazole and Famotidine for Stress Ulcer Prophylaxis in Neurosurgical Intensive Care Unit [Recruiting]

more>>